FILTER
FILTERED INTERVIEW RESULTS
Shankar Musunuri
CHAIRMAN, CEO & CO-FOUNDER, OCUGEN
Ocugen explains its work on cures for unmet needs in the ophthalmology space and COVID-19 vaccine development.
Massimiliano Rocchi
SENIOR DIRECTOR ITALY AND GREECE, ACCORD HEALTHCARE ITALIA
Accord Healthcare Italia explains the challenges and opportunities for generics producers in Italy.
Luca Crippa
CEO & MANAGING DIRECTOR, IBSA FARMACEUTICI
Instituto Biochimico, with 2,000 global employees, is attempting to take generics to the next level and continue to expand around the world.
Franco Lori
CEO & FOUNDER, VIROSTATICS
Virostatics is a private drug discovery and development company focused on NCEs used in the treatment of cancers and viral diseases.
Brian Frenzel
PRESIDENT & CEO, TOSK
Tosk explains how it is successfully developing drugs to counter the side effects of cancer therapies.
Prasad Raje
CEO, LGM PHARMA
LGM Pharma explains how working with a smaller CDMO with extensive experience and partnerships can be beneficial.
Ramin Cyrus
VICE PRESIDENT MARKETING, LONZA CAPSULES AND HEALTH INGREDIENTS
Lonza Capsules and Health Ingredients comments on market trends.
Vivek Sharma
CEO, ADARE PHARMA SOLUTIONS
Adare Pharma Solutions explains how it is expanding its range as a leading technology-driven CDMO.
John Huang
CEO, THEWELL BIOSCIENCE
TheWell Bioscience is a biomedical technology company providing innovative 3D cell platforms for drug discovery, cell therapy and personalized medicine.
Cosimo Lenti
BUSINESS DIRECTOR, DIATHEVA
Diatheva promotes biotechnological innovation by providing high-value customized diagnostic kits and solutions.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2024 - Digital Interactive
"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "
"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
